Skip to content

CRSP

CRISPR Therapeutics AG

Key figures

MetricLast 12 months5-year CAGR
Revenue$25M+37.3%
Operating income−$532M—
Net income−$456M—
EPS−$4.74—
Free cash flow−$377M—